Stocks Are Going Back on Sale As Vaccine Rallies Fade

Stocks like Aphria (TSX:APHA)(NASDAQ:APHA) are going back on sale as post-election vaccine bullishness begins to recede.

analyze data

Image source: Getty Images

Uncertainty in the markets can cause investors to make snap decisions. The U.S. election saw the markets flipflop as the democrat landslide failed to materialize. While Joe Biden has since emerged as as the president-elect, the politics of our southerly neighbours remain starkly divided. The pandemic has also thrown mixed messages into the news cycle, with rising cases pitched against vaccine hopes.

Stock market volatility continues

But uncertainty itself is not the problem. The markets were bathed in uncertainty last year. From weak oil to the trade war to valuation anxiety, 2019 had worries aplenty. But investors carried on buying right up until the March crash. Instead, the real problem right now is indecision. This can be seen in the way that the TSX Composite Index has flattened out this week.

Investors are beginning to ease back out of value stocks. But growth stocks are also slowing down at the same time. The markets are holding their breath. Markets are weighing such disparate stocks as Aphria against names like Barrick Gold and Newmont. Both asset types have seen intense momentum this year but are now grinding to a halt.

This holding pattern is fairly rare in 2020. The year to date has been typified by wildly oscillating momentum. Huge dips have been offset by heroic rips. But the current sentiment is becoming somewhat neutral. While greed has lately predominated over fear, stocks are nevertheless caught between rapidly alternating patterns.

Indeed, the CBOE Volatility Index (VIX) is currently pointing to 22.19. This sometimes overlooked indicator shows a neutral market right now. The amount of 52-week highs compared to yearlong lows is also fairly neutral at the moment. This neutrality belies a market that could flip either way.

Keep cash on hand for buying opportunities

The situation probably won’t last long, though. The vaccine bullishness that has been buoying the markets is already beginning to turn into a disillusioned selloff. With businesses still reporting earnings, there may be some upside still to be gleaned, especially from bank stocks. A resolved political situation south of the border could also help to lift stocks.

However, vaccine hopes are still 2020’s fairy gold, turning into sacks of leaves overnight. Until the uncertainties in the market are erased – from U.S. election shenanigans to the pandemic itself – then the selloffs will keep erasing the rallies.

It will take a successful vaccination program to kickstart a sustained bull run. And even then, the uncertainties that preexisted the pandemic will have to be mitigated.

Until then, bargains can still be had. Look at Aphria, for instance, down 1.3% at the time of writing. Barrick is down by the same amount,which renders both stocks key contrarian picks this week. As the reality of the pandemic continues to sink in, investors are going to be selling a lot of quality picks.

Value opportunities are therefore likely to continue opening up. By buying shares while they’re in the red, investors can continue to keep calm and carry on building positions.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »